Literature DB >> 36085498

Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer?

Simone Albisinni1,2,3, Julien Sarkis4, Romain Diamand4,5, Cosimo De Nunzio6.   

Abstract

Entities:  

Year:  2022        PMID： 36085498     DOI： 10.1038/s41391-022-00593-8

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.455


× No keyword cloud information.
  20 in total

1.  Detection and localisation of primary prostate cancer using 68 gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology.

Authors:  Arveen A Kalapara; Tatenda Nzenza; Henry Y C Pan; Zita Ballok; Shakher Ramdave; Richard O'Sullivan; Andrew Ryan; Martin Cherk; Michael S Hofman; Badrinath R Konety; Nathan Lawrentschuk; Damien Bolton; Declan G Murphy; Jeremy P Grummet; Mark Frydenberg
Journal:  BJU Int       Date:  2020-07       Impact factor: 5.588

2.  Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy.

Authors:  Mehmet Onur Demirkol; Tarik Esen; Ersin Koseoglu; Yakup Kordan; Mert Kilic; Oguzhan Sal; Hulya Seymen; Murat Can Kiremit; Ayse Armutlu; Dilek Ertoy Baydar; Emre Altinmakas; Metin Vural; Okan Falay; Abdullah Erdem Canda; Derya Balbay
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-08-21       Impact factor: 5.554

3.  Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?

Authors:  Valeria Panebianco; Giovanni Barchetti; Giuseppe Simone; Maurizio Del Monte; Antonio Ciardi; Marcello Domenico Grompone; Riccardo Campa; Elena Lucia Indino; Flavio Barchetti; Alessandro Sciarra; Costantino Leonardo; Michele Gallucci; Carlo Catalano
Journal:  Eur Urol       Date:  2018-03-19       Impact factor: 20.096

4.  Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection.

Authors:  D J H Baas; M Schilham; R Hermsen; J M S de Baaij; H J E J Vrijhof; R J Hoekstra; J P M Sedelaar; H V N Küsters-Vandevelde; M Gotthardt; C H W Wijers; J P van Basten; D M Somford
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-09-01       Impact factor: 5.554

5.  The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.

Authors:  Louise Emmett; James Buteau; Nathan Papa; Daniel Moon; James Thompson; Matthew J Roberts; Kris Rasiah; David A Pattison; John Yaxley; Paul Thomas; Anthony C Hutton; Shikha Agrawal; Amer Amin; Alexandar Blazevski; Venu Chalasani; Bao Ho; Andrew Nguyen; Victor Liu; Jonathan Lee; Gemma Sheehan-Dare; Raji Kooner; Geoff Coughlin; Lyn Chan; Thomas Cusick; Benjamin Namdarian; Jada Kapoor; Omar Alghazo; Henry H Woo; Nathan Lawrentschuk; Declan Murphy; Michael S Hofman; Phillip Stricker
Journal:  Eur Urol       Date:  2021-08-28       Impact factor: 20.096

6.  Tissue-based biomarkers in prostate cancer.

Authors:  Timothy N Clinton; Aditya Bagrodia; Yair Lotan; Vitaly Margulis; Ganesh V Raj; Solomon L Woldu
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-09-05

7.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

8.  Findings in 1,123 Men with Preoperative 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer.

Authors:  S Raveenthiran; W J Yaxley; T Franklin; G Coughlin; M Roberts; T Gianduzzo; B Kua; H Samaratunga; B Delahunt; L Egevad; D Wong; L McEwan; N Brown; R Parkinson; R Esler; J W Yaxley
Journal:  J Urol       Date:  2021-10-25       Impact factor: 7.600

9.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

10.  Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study.

Authors:  Daniel Eberli; Irene A Burger; Daniela A Ferraro; Anton S Becker; Benedikt Kranzbühler; Iliana Mebert; Anka Baltensperger; Konstantinos G Zeimpekis; Hannes Grünig; Michael Messerli; Niels J Rupp; Jan H Rueschoff; Ashkan Mortezavi; Olivio F Donati; Marcelo T Sapienza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-23       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.